Nomura Holdings Inc ADR (NMR)
Official siteFINANCIAL SERVICES • CAPITAL MARKETS • NYSE
Market Cap: $28.35B
Last updated: Nov 17, 2026 at 4:15 PM ET
Nomura Holdings Inc ADR (NMR) Stock Chart
Nomura Holdings Inc ADR (NMR) has a latest price of $9.34 on Nov 17, 2026, 13.1% below its 52-week high of $10.75. Its price rose 26.4% over the past 12 months. The month-end price rose 88.4% over the 10 years through Oct 2026, a compound annual rate of 6.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $10.18 in Aug 2026 and its lowest $3.11 in May 2019, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NMR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NMR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 1.8%, and over 6 months it rose 16.8%. The month-end price rose 142.4% over the 3 years through Oct 2026, a compound annual rate of 34.3%.
| Period | Change |
|---|---|
| 1 month | +2.4% |
| 3 months | -1.8% |
| 6 months | +16.8% |
| 12 months | +26.4% |
| 12 months, with dividends | +28.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +142.4% | +34.3% |
| 5 years | +103.5% | +15.3% |
| 10 years | +88.4% | +6.5% |
Price by Year
Its best calendar year was 2025, when the price rose 44.9%, and its weakest was 2018, when it fell 36.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.38 | +11.8% |
| 2025 | $8.39 | +44.9% |
| 2024 | $5.79 | +28.4% |
| 2023 | $4.51 | +20.3% |
| 2022 | $3.75 | -13.4% |
| 2021 | $4.33 | -18.8% |
| 2020 | $5.33 | +3.3% |
| 2019 | $5.16 | +38.7% |
| 2018 | $3.72 | -36.1% |
| 2017 | $5.82 | -1.4% |
Trading Range
The price is 3.6% below its 50-day average of $9.69 and 3.8% above its 200-day average of $9.00.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $9.34 | |
| 52-week high | $10.75 | -13.1% |
| 52-week low | $6.70 | +39.4% |
| 50-day average | $9.69 | -3.6% |
| 200-day average | $9.00 | +3.8% |
Price Risk
Over 3 years, its largest fall from a peak was 26.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.14 |
| Largest fall, 1 year | -22.7% |
| Largest fall, 3 years | -26.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NMR
What is NMR's 1-year price change?
Nomura Holdings Inc ADR's price rose 26.4% over the past 12 months. With dividends included, the 12-month total return was 28.4%.
What is NMR's 5-year price change?
Nomura Holdings Inc ADR's month-end price rose 103.5% over the 5 years through Oct 2026, a compound annual rate of 15.3%. These figures leave out dividends.
What is NMR's 52-week high and low?
Nomura Holdings Inc ADR's 52-week high is $10.75 and its 52-week low is $6.70. Its latest price of $9.34 on Nov 17, 2026 is 13.1% below the high.
What is NMR's beta?
Nomura Holdings Inc ADR's 1-year beta against the S&P 500 is 1.14, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 22.7%.
Is the NMR chart free?
Yes. Advanced Charting for NMR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NMR pages: Overview, Dividends, Charting, Financials, Statistics, Valuation, Competitors